NCT03393364View on ClinicalTrials.gov

Pain Management in Outpatient Urologic Procedures

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Urologic Diseases
Interventions
DRUG

Oxycodone

Patients receive oxycodone for pain control after outpatient urologic surgery.

DRUG

Ketorolac

Patients receive ketorolac for pain control after outpatient urologic surgery

Trial Locations (1)

44110

University Hospitals, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT03393364 - Pain Management in Outpatient Urologic Procedures | Biotech Hunter | Biotech Hunter